PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,227 | -4.3% | 532,079 | 0.0% | 0.02% | 0.0% |
| Q2 2023 | $9,641 | -31.7% | 532,079 | +0.2% | 0.02% | -41.2% |
| Q1 2023 | $14,121 | +31.7% | 530,896 | -4.3% | 0.03% | +30.8% |
| Q4 2022 | $10,726 | -99.9% | 554,891 | -5.8% | 0.03% | -18.8% |
| Q3 2022 | $12,310,000 | +186.0% | 589,266 | +9.7% | 0.03% | +190.9% |
| Q2 2022 | $4,304,000 | +14.3% | 537,379 | 0.0% | 0.01% | +37.5% |
| Q1 2022 | $3,767,000 | -48.1% | 537,379 | 0.0% | 0.01% | -46.7% |
| Q4 2021 | $7,255,000 | -20.0% | 537,379 | 0.0% | 0.02% | -21.1% |
| Q3 2021 | $9,071,000 | -42.0% | 537,379 | 0.0% | 0.02% | -44.1% |
| Q2 2021 | $15,648,000 | -26.0% | 537,379 | 0.0% | 0.03% | -33.3% |
| Q1 2021 | $21,135,000 | +73.1% | 537,379 | 0.0% | 0.05% | +59.4% |
| Q4 2020 | $12,209,000 | +0.3% | 537,379 | 0.0% | 0.03% | -11.1% |
| Q3 2020 | $12,172,000 | -30.2% | 537,379 | 0.0% | 0.04% | -34.5% |
| Q2 2020 | $17,443,000 | – | 537,379 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
| TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
| CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
| GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
| VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
| Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
| Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
| Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
| Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
| First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |